methamphetamine has been researched along with luzindole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Govitrapong, P; Wongprayoon, P | 1 |
Govitrapong, P; Jumnongprakhon, P; Sivasinprasasn, S; Tocharus, C; Tocharus, J | 1 |
2 other study(ies) available for methamphetamine and luzindole
Article | Year |
---|---|
Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line.
Topics: Antioxidants; Cell Line, Tumor; Central Nervous System Stimulants; Culture Media, Serum-Free; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Inflammation; Melatonin; Methamphetamine; Neuroblastoma; Protein Transport; Receptors, Melatonin; RNA, Small Interfering; Time Factors; Transfection; Tryptamines; Tumor Necrosis Factor-alpha | 2015 |
Activation of melatonin receptor (MT1/2) promotes P-gp transporter in methamphetamine-induced toxicity on primary rat brain microvascular endothelial cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Cells, Cultured; Central Nervous System Stimulants; Endothelial Cells; Melatonin; Methamphetamine; Microvessels; Neuroprotective Agents; Rats; Reactive Nitrogen Species; Reactive Oxygen Species; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Rhodamine 123; Tryptamines; Verapamil | 2017 |